Which has the lower trailing P/E, COR or EW?

COR has the lower trailing P/E: COR trades at 24.80 and EW at 52.89. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, COR or EW?

Over the past five years, COR grew revenue faster — COR at a 10.25% CAGR versus EW at 5.75%.

Does COR or EW pay a bigger dividend?

COR pays a dividend (0.70% yield), while EW has no payments in the available dividend history.

Is COR or EW more profitable?

EW runs the higher net margin — COR at 0.79% versus EW at 15.43%.

How have COR and EW total returns compared?

Over the past 10 years, COR delivered 16.15% and EW delivered 9.25% annualized total return. Past performance doesn't predict future results.

Cencora, Inc. (COR) vs Edwards Lifesciences Corporation (EW)

A side-by-side comparison of Cencora, Inc. and Edwards Lifesciences Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 12, 2026. Differences are shown without an overall score or investment verdict.

COR

Cencora, Inc.

$64.96B

$333.87HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

Edwards Lifesciences Corporation

$53.93B

$93.66HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

Total return — COR vs EW

growth of $100 · dividends reinvested · last 10y

COR +330.4% (+15.7%/yr)EW +144.9% (+9.4%/yr)COR compounded faster over this window

COR EW

COR vs EW: by the numbers

•COR is the larger company ($64.96B vs $53.93B market cap).
•COR trades at the lower trailing earnings multiple (24.80 vs 52.89 P/E), one valuation lens rather than an overall verdict.
•EW converts more revenue to profit (15.43% vs 0.79% net margin).
•COR grew revenue faster over the past five years (10.25% vs 5.75% CAGR).
•COR pays a dividend (0.70% yield), while EW has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	COR	EW
P/E ratio	24.80	52.89
Forward P/E	18.74	30.67
P/S ratio	0.19	8.16
P/B ratio	19.99	5.01
EV / EBITDA	13.67	25.54
FCF yield	6.27%	2.70%

Profitability

Metric	COR	EW
Gross margin	3.71%	77.98%
Operating margin	1.30%	28.09%
Net margin	0.79%	15.43%
ROE	81.03%	9.46%
ROIC	13.23%	11.40%

Dividends

Metric	COR	EW
Dividend yield	0.70%	N/A
Payout ratio	29.30%	N/A

Growth (annualized)

Metric	COR	EW
Revenue CAGR (5Y)	10.25%	5.75%
EPS CAGR (5Y)	11.97%	6.87%
FCF CAGR (5Y)	9.63%	6.41%
Total return CAGR (5Y)	24.14%	-3.84%

Frequently asked

Which has the lower trailing P/E, COR or EW?: COR has the lower trailing P/E: COR trades at 24.80 and EW at 52.89. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, COR or EW?: Over the past five years, COR grew revenue faster — COR at a 10.25% CAGR versus EW at 5.75%.
Does COR or EW pay a bigger dividend?: COR pays a dividend (0.70% yield), while EW has no payments in the available dividend history.
Is COR or EW more profitable?: EW runs the higher net margin — COR at 0.79% versus EW at 15.43%.
How have COR and EW total returns compared?: Over the past 10 years, COR delivered 16.15% and EW delivered 9.25% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COR analysis Full EW analysis Interactive comparison tool

Dig into the metrics

Cencora P/E ratio Edwards Lifesciences P/E ratio Cencora dividend yield Cencora ROE Edwards Lifesciences ROE Cencora operating margin Edwards Lifesciences operating margin Cencora revenue growth Edwards Lifesciences revenue growth Cencora free cash flow Edwards Lifesciences free cash flow

Cencora & Edwards Lifesciences appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 12, 2026.